138 related articles for article (PubMed ID: 28860066)
1. Novel peptide MT23 for potent penetrating and selective targeting in mouse melanoma cancer cells.
Zhou N; Wu J; Qin YY; Zhao XL; Ding Y; Sun LS; He T; Huang XW; Liu CB; Wang H
Eur J Pharm Biopharm; 2017 Nov; 120():80-88. PubMed ID: 28860066
[TBL] [Abstract][Full Text] [Related]
2. Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.
Wang H; Ma JL; Yang YG; Song Y; Wu J; Qin YY; Zhao XL; Wang J; Zou LL; Wu JF; Li JM; Liu CB
Oncotarget; 2016 Aug; 7(31):49075-49090. PubMed ID: 27081693
[TBL] [Abstract][Full Text] [Related]
3. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
Gao H; Zhang Q; Yang Y; Jiang X; He Q
Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
8. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
10. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
11. Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.
Zhang L; Zhang Y; Tai L; Jiang K; Xie C; Li Z; Lin YZ; Wei G; Lu W; Pan W
Acta Biomater; 2016 Sep; 42():90-101. PubMed ID: 27370905
[TBL] [Abstract][Full Text] [Related]
12. A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death.
Jagot-Lacoussiere L; Kotula E; Villoutreix BO; Bruzzoni-Giovanelli H; Poyet JL
Cancer Res; 2016 Sep; 76(18):5479-90. PubMed ID: 27406828
[TBL] [Abstract][Full Text] [Related]
13. A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery.
Hoffmann K; Milech N; Juraja SM; Cunningham PT; Stone SR; Francis RW; Anastasas M; Hall CM; Heinrich T; Bogdawa HM; Winslow S; Scobie MN; Dewhurst RE; Florez L; Ong F; Kerfoot M; Champain D; Adams AM; Fletcher S; Viola HM; Hool LC; Connor T; Longville BAC; Tan YF; Kroeger K; Morath V; Weiss GA; Skerra A; Hopkins RM; Watt PM
Sci Rep; 2018 Aug; 8(1):12538. PubMed ID: 30135446
[TBL] [Abstract][Full Text] [Related]
14. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter.
Higa M; Katagiri C; Shimizu-Okabe C; Tsumuraya T; Sunagawa M; Nakamura M; Ishiuchi S; Takayama C; Kondo E; Matsushita M
Biochem Biophys Res Commun; 2015 Feb; 457(2):206-12. PubMed ID: 25562654
[TBL] [Abstract][Full Text] [Related]
16. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
17. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
18. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
19. Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells.
Soni N; Jyoti K; Jain UK; Katyal A; Chandra R; Madan J
Biomed Pharmacother; 2017 Jun; 90():906-913. PubMed ID: 28441716
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
